Resultados de la búsqueda 251-260 of 23168 for Two-phase
... phase II dose (RP2D of APG2575 in combination with Pomalidomide ... In Part 2, the step-up dose identified in Part 1 will be used followed by ...
... two anti-hypertensive medications and lifestyle changes. ... This phase Ib trial studies the side effects and ... Ir a página 22 · Ir a página 33 · Ir a ...
ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose optimization (Part ...
1) in patients with relapsed and/or refractory diffuse large B cell lymphoma (DLBCL) after receiving at least two lines of therapy. ... phase 2 dose (RP2D) for ...
Rochester, Minn. This is an international phase III trial, with a Bayesian design, incorporating two sequential randomisations. It efficiently examines a ...
The purpose of this study is to investigate outcomes for all patients with upper or lower extremity lymphedema with lymph node transfer in a two stage ...
... phase. A Study to Evaluate EAA181 to Treat Newly-diagnosed Multiple Myeloma ... two prior lines of therapies. The study has 2 Modules: Module 1 for FL and Module ...
... two cycles of mosunetuzumab. An additional arm (open to non-US ... The purpose of phase 2 of this trial is to evaluate the effectiveness of ...
... phase 2 dose (RP2D) for future study after treatment with SONALA-001 in combination with MRgFUS in subjects with progressive or rGBM. Extracellular Impact ...
This is a Phase 2 global, multi-center, open-label study to assess the efficacy, safety and tolerability of AZD0486 monotherapy in adult participants with ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?